Tel: | +86-21-31433387 |
+86-15618786686 | |
Email: | sales@rechemscience.com |
info@rechemscience.com | |
QQ: | 1369748377 |
Skype: | sales@rechemscience.com |
Cat.No. | Product name | Product Description |
R10036 | XL880; Foretinib; GSK136308 | Foretinib (GSK1363089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly |
R10077 | AMG208 | AMG 208 is a highly selective c-Met inhibitor with IC50 of 9 nM. Phase 1. |
R10078 | EMD1214063 | Tepotinib (EMD 1214063) is a potent and selective c-Met inhibitor with IC50 of 4 |
R10143 | Cabozantinib (XL184; BMS-907351) | Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 |
R10785 | Savolitinib (Volitinib; HMPL-504; AZD-6094) | Savolitinib(Volitinib; AZD-6094; Volitinib) is an orally bioavailable inhibitor |
R10837 | INCB28060 | Capmatinib (INCB28060) is a novel, ATP-competitive inhibitor of c-MET with IC50 |
R11523 | BMS-794833 | BMS-794833 is a potent ATP competitive inhibitor of Met/VEGFR2 with IC50 of 1.7 |